Doorn, P.A. van

patient study treatment disease antibody syndrome muscle fatigue neurology score nerve jejuni group trial infection neurol motor demyelinating disability pompe disease scale pompe flammatory demyelinating polyradiculoneuropathy neuropathy guillain-barre syndrome van doorn pa exacerbation value outcome response guillain-barr é syndrome therapy flammatory immunoglobulin gbs patients weakness level doorn polyneuropathy effect guillain-barre serum table flammatory demyelinating polyneuropathy ganglioside netherland activity factor result function improvement signi baseline journal placebo period month sclerosis symptom change measure campylobacter plasma exchange strength course point rotterdam university onset range erasmus mc mrc sum score demyelinating polyneuropathy department difference igiv-c disorder analysis reactivity conduction